Madison startup gets FDA approval for radiation assessment tool

A Madison startup called Voximetry has received FDA clearance for a tool that estimates the amount of radiation absorbed by patients following treatment or diagnosis with radiopharmaceuticals, according to a report from Wisbusiness.com.

This class of drugs uses radioactive isotopes for diagnostic or therapeutic purposes. The amount of radiation used for diagnostics is typically very low, but when used to treat cancer and some other diseases, a higher dose is often used.

In a statement, Voximetry CEO Sue Wallace said the agency’s approval represents “an important first step on the path to accurate personalized treatments that may include increased tumor response or improved protection for critical organs.”